Clinical Trials
8
Active:4
Completed:4
Trial Phases
1 Phases
Phase 1:8
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 1
8 (100.0%)A Food Effect Study With ZN-c5 in Healthy Post-Menopausal Subjects
- First Posted Date
- 2020-09-24
- Last Posted Date
- 2020-12-23
- Lead Sponsor
- Zeno Alpha Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04561752
- Locations
- 🇳🇿
Site 1, Christchurch, New Zealand
A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Zeno Alpha Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT04514159
- Locations
- 🇺🇸
Site 2, Gilbert, Arizona, United States
🇺🇸Site 1, Charleston, South Carolina, United States
🇵🇱Site 6, Grudziądz, Poland
A Study of ZN-c5 in Participants With Breast Cancer
- First Posted Date
- 2019-11-25
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Zeno Alpha Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT04176757
- Locations
- 🇺🇸
Site 3, Tucson, Arizona, United States
🇺🇸Site 2, New York, New York, United States
🇺🇸Site 4, Nashville, Tennessee, United States
A Study of ZN-c5 in Subjects With Breast Cancer
- First Posted Date
- 2018-06-18
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Zeno Alpha Inc.
- Target Recruit Count
- 181
- Registration Number
- NCT03560531
- Locations
- 🇺🇸
Site 3, Tucson, Arizona, United States
🇺🇸Site 5, Los Angeles, California, United States
🇺🇸Site 48, Bethesda, Maryland, United States
News
No news found